These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17893693)

  • 21. [Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].
    Rotanov M; Grebennikova TV; Burtseva EI; Shevchenko ES
    Mol Gen Mikrobiol Virusol; 2008; (2):27-32. PubMed ID: 18488446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distinct role of T cell costimulation in antiviral immunity.
    Welten SP; Melief CJ; Arens R
    Curr Opin Virol; 2013 Aug; 3(4):475-82. PubMed ID: 23850168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives on antiviral drug development.
    Wainberg MA
    Antiviral Res; 2009 Jan; 81(1):1-5. PubMed ID: 18948140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Resistance in influenza viruses].
    Hungnes O; Dudman SG
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8+ regulatory T cells in persistent human viral infections.
    Billerbeck E; Thimme R
    Hum Immunol; 2008 Nov; 69(11):771-5. PubMed ID: 18789990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-deoxy-D-glucose as a potential drug against fusogenic viruses including HIV.
    Parris GE
    Med Hypotheses; 2008; 70(4):776-82. PubMed ID: 17920779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza.
    Hill AW; Guralnick RP; Wilson MJ; Habib F; Janies D
    Infect Genet Evol; 2009 Mar; 9(2):169-78. PubMed ID: 19022400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased virus replication in mammalian cells by blocking intracellular innate defense responses.
    de Vries W; Haasnoot J; van der Velden J; van Montfort T; Zorgdrager F; Paxton W; Cornelissen M; van Kuppeveld F; de Haan P; Berkhout B
    Gene Ther; 2008 Apr; 15(7):545-52. PubMed ID: 18273055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of action of antiviral drugs].
    Shiraki K; Daikoku T; Takemoto M; Himaki T; Kuramoto T
    Nihon Rinsho; 2012 Apr; 70(4):545-51. PubMed ID: 22568132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mechanisms of the formation of viral resistance to chemotherapeutic preparations].
    Chizhov NP
    Vopr Virusol; 1985; 30(3):266-79. PubMed ID: 3901520
    [No Abstract]   [Full Text] [Related]  

  • 32. [The inclusion of host antigens into the structure of viruses].
    Rovnova ZI
    Usp Sovrem Biol; 1966; 61(3):415-25. PubMed ID: 4881273
    [No Abstract]   [Full Text] [Related]  

  • 33. IL-10 and the resolution of infections.
    Filippi CM; von Herrath MG
    J Pathol; 2008 Jan; 214(2):224-30. PubMed ID: 18161757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007).
    Pabbaraju K; Ho KC; Wong S; Shokoples S; Pang XL; Fonseca K; Fox JD
    Antiviral Res; 2008 Aug; 79(2):81-6. PubMed ID: 18258311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel strategies to eliminate persistent viral infections.
    Martinic MM; von Herrath MG
    Trends Immunol; 2008 Mar; 29(3):116-24. PubMed ID: 18258483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.
    Deyde VM; Okomo-Adhiambo M; Sheu TG; Wallis TR; Fry A; Dharan N; Klimov AI; Gubareva LV
    Antiviral Res; 2009 Jan; 81(1):16-24. PubMed ID: 18835410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immune response to viral infection.
    Koyama S; Ishii KJ; Coban C; Akira S
    Cytokine; 2008 Sep; 43(3):336-41. PubMed ID: 18694646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convergent mechanisms of genome evolution of large and giant DNA viruses.
    Filée J; Chandler M
    Res Microbiol; 2008 Jun; 159(5):325-31. PubMed ID: 18572389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The viral eukaryogenesis hypothesis: a key role for viruses in the emergence of eukaryotes from a prokaryotic world environment.
    Bell PJ
    Ann N Y Acad Sci; 2009 Oct; 1178():91-105. PubMed ID: 19845630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.